PARP1 inhibitors in breast cancer therapy. Mechanism of action and clinical use
It is known that currently PARP inhibitors are actively used in the treatment of tumors of the female reproductive system. A large number of studies have been presented demonstrating the effectiveness of PARP inhibitors in the treatment of BRCA-associated ovarian cancer. It was found that mutations...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2020-06-01
|
| Series: | Opuholi Ženskoj Reproduktivnoj Sistemy |
| Subjects: | |
| Online Access: | https://ojrs.abvpress.ru/ojrs/article/view/703 |